Véronique Minard‐Colin

Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3)

Jérôme Feldmann, Isabelle Callebaut, Graça Raposo et al. · Cell · 2003 · 916 citations · Full text

Is Mutated, Lymphoid Neoplasia, Hematological Malignancy +8

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Véronique Minard‐Colin, Anne Aupérin, Marta Pillon et al. · New England Journal of Medicine · 2020 · 298 citations · Full text

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron et al. · The Lancet Oncology · 2019 · 231 citations · Full text

Oncology, Metronomic Therapy, Rms 2005 +9

Real‐Time Blood Plasma Polymerase Chain Reaction for Management of Disseminated Adenovirus Infection

Marianne Leruez‐Ville, Véronique Minard‐Colin, Florence Lacaille et al. · Clinical Infectious Diseases · 2003 · 188 citations

Diagnostic Virology, Adenovirus Infection, Viral Persistence +10

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Gianni Bisogno, Meriel Jenney, Christophe Bergeron et al. · The Lancet Oncology · 2018 · 182 citations

Oncology, Medicine, Dose-intensified Doxorubicin +10